A single-centre study evaluating a geriatric screening tool in oncology phase I trial patients.

Autor: Van Zyl M; Drug Development Unit, Royal Marsden Hospital/Institute of Cancer Research, Sutton, UK., Barell A; Senior Adult Oncology Programme, Royal Marsden Hospital, Sutton, UK., Cooley B; Drug Development Unit, Royal Marsden Hospital/Institute of Cancer Research, Sutton, UK., Hanwell J; Drug Development Unit, Royal Marsden Hospital/Institute of Cancer Research, Sutton, UK., Parlak J; Drug Development Unit, Royal Marsden Hospital/Institute of Cancer Research, Sutton, UK., Banerji U; Drug Development Unit, Royal Marsden Hospital/Institute of Cancer Research, Sutton, UK., De Bono J; Drug Development Unit, Royal Marsden Hospital/Institute of Cancer Research, Sutton, UK., Sharp A; Drug Development Unit, Royal Marsden Hospital/Institute of Cancer Research, Sutton, UK., Lopez J; Drug Development Unit, Royal Marsden Hospital/Institute of Cancer Research, Sutton, UK., Battisti NML; Senior Adult Oncology Programme, Royal Marsden Hospital, Sutton, UK.; Breast Unit & Senior Adult Oncology Programme, Royal Marsden Hospital, Sutton, UK., Minchom A; Drug Development Unit, Royal Marsden Hospital/Institute of Cancer Research, Sutton, UK.

Publikováno v: Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2024 Jun; Vol. 7 (6), pp. e2083.

CN37 - Evaluation of support and information needs for patients with cancer in a phase I trials unit

Autor: Stapleton, S., O’Leary, L., van Zyl, M., Hanwell, J., Wiseman, T.

Publikováno v: In Annals of Oncology October 2018 29 Supplement 8

Metabolism, excretion and pharmacokinetics of a single dose of [14C]-raltitrexed in cancer patients.

Autor: Beale, P., Judson, I., Hanwell, J., Berry, C., Aherne, W., Hickish, T., Martin, P., Walker, M.

Publikováno v: Cancer Chemotherapy & Pharmacology; May1998, Vol. 42 Issue 1, p71-76, 6p

A study of motivations and expectations of patients seen in phase 1 oncology clinics.

Autor: Dolly SO; Department of Medicine, Royal Marsden NHS Foundation Trust, London, United Kingdom.; Division of Clinical Studies, Institute of Cancer Research, London, United Kingdom., Kalaitzaki E; Clinical R&D, Royal Marsden NHS Foundation Trust, London, United Kingdom., Puglisi M; Department of Medicine, Royal Marsden NHS Foundation Trust, London, United Kingdom.; Division of Clinical Studies, Institute of Cancer Research, London, United Kingdom., Stimpson S; Division of Clinical Studies, Institute of Cancer Research, London, United Kingdom., Hanwell J; Department of Medicine, Royal Marsden NHS Foundation Trust, London, United Kingdom.; Division of Clinical Studies, Institute of Cancer Research, London, United Kingdom., Fandos SS; Division of Clinical Studies, Institute of Cancer Research, London, United Kingdom., Stapleton S; Department of Medicine, Royal Marsden NHS Foundation Trust, London, United Kingdom.; Division of Clinical Studies, Institute of Cancer Research, London, United Kingdom., Ansari T; Division of Clinical Studies, Institute of Cancer Research, London, United Kingdom., Peckitt C; Clinical R&D, Royal Marsden NHS Foundation Trust, London, United Kingdom., Kaye S; Department of Medicine, Royal Marsden NHS Foundation Trust, London, United Kingdom.; Division of Clinical Studies, Institute of Cancer Research, London, United Kingdom., Lopez J; Department of Medicine, Royal Marsden NHS Foundation Trust, London, United Kingdom.; Division of Clinical Studies, Institute of Cancer Research, London, United Kingdom., Yap TA; Department of Medicine, Royal Marsden NHS Foundation Trust, London, United Kingdom.; Division of Clinical Studies, Institute of Cancer Research, London, United Kingdom., van der Graaf W; Department of Medicine, Royal Marsden NHS Foundation Trust, London, United Kingdom.; Division of Clinical Studies, Institute of Cancer Research, London, United Kingdom., de Bono J; Department of Medicine, Royal Marsden NHS Foundation Trust, London, United Kingdom.; Division of Clinical Studies, Institute of Cancer Research, London, United Kingdom., Banerji U; Department of Medicine, Royal Marsden NHS Foundation Trust, London, United Kingdom.; Division of Clinical Studies, Institute of Cancer Research, London, United Kingdom.

Publikováno v: Cancer [Cancer] 2016 Nov 15; Vol. 122 (22), pp. 3501-3508. Date of Electronic Publication: 2016 Sep 26.

105 A Clinical Audit on the Patients' Experience of a Phase I Trial in a Clinical Trials Unit

Autor: Stapleton, S., Hanwell, J., Woolven, M.

Publikováno v: In European Journal of Oncology Nursing 26 April 2012 16 Supplement 1:S38-S38